Skip to main content
Have a personal or library account? Click to login
The correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus Cover

The correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 1 (March 2016)
By: ,  ,  ,   and    
Open Access
|Mar 2016
References

References

  1. 1. Bright GM, Melton TW, Rogol AD, Clarke WL. Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics. Diabetes 1980; 29(8):662-4. DOI: 10.2337/diab.29.8.662
    Open DOISearch in Google Scholar
  2. 2. Bolli GB, Gerich JE. The “dawn-phenomenon” a common occurrence in both non-insulindependent and insulin-dependent diabetes mellitus. N Engl J Med. 1984; 310(12):746–50. DOI: 10.1056/NEJM198403223101203
    Open DOISearch in Google Scholar
  3. 3. Shih KC, Hsieh SH, Kwok CF, Hwu CM, Hsieh PS, Ho LT. Effect of growth hormone on dawn phenomenon in patients with type 2 diabetes Growth Factors. 2013;31(2):66-73. DOI: 10.3109/08977194.2013.772996
    Open DOISearch in Google Scholar
  4. 4. Carroll MF, Schade DS. The dawn phenomenon revisited: implications for diabetes therapy. Endocr Pract. 2005;11(1):55–64. DOI: 10.4158/EP.11.1.55
    Open DOISearch in Google Scholar
  5. 5. Atiea JA, Luzio S, Owens DR. The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients. Diabetes Res Clin Pract 1992;16(3):183–190. Carroll MF, Hardy KJ, Burge MR, Schade DS. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy. Diabetes Technol Ther. 2002;4(5):595–605. DOI: 10.1089/152091502320798213
    Open DOISearch in Google Scholar
  6. 6. Campbell PJ, Bolli GB, Cryer PE, Gerich JE. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med. 1985 Jun 6;312(23):1473-9. DOI: 10.1056/NEJM198506063122302
    Open DOISearch in Google Scholar
  7. 7. Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981;4(6):579–85. DOI: 10.2337/diacare.4.6.579
    Open DOISearch in Google Scholar
  8. 8. D’Alessio D. The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab. 2011 Oct;13 Suppl 1:126-32. DOI: 10.1111/j.1463-1326.2011.01449.x
    Open DOISearch in Google Scholar
  9. 9. Monnier L, Colette C, Dejager S, Owens D. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care. 2013;36(12):4057–62. DOI: 10.2337/dc12-2127
    Open DOISearch in Google Scholar
  10. 10. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c independent risk factor for diabetic complications. J Am Med Assoc. 2006;295(14):1707–8. DOI: 10.1001/jama.295.14.1707
    Open DOISearch in Google Scholar
  11. 11. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2009;32(10):1901-3. DOI: 10.2337/dc09-0109
    Open DOISearch in Google Scholar
  12. 12. Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, Ceriello A. Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract. 2013;102(2):86-95. DOI: 10.1016/j.diabres.2013.09.007
    Open DOISearch in Google Scholar
  13. 13. Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF, et al. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014;6(1):139. DOI: 10.1186/1758-5996-6-139
    Open DOISearch in Google Scholar
  14. 14. Smith-Palmer J, Brändle M, Trevisan R, Orsini Federici M, Liabat S, Valentine W. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(3):273-84. DOI: 10.1016/j.diabres.2014.06.007
    Open DOISearch in Google Scholar
  15. 15. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation. 1997;96(6):1750–4. DOI: 10.1161/01.CIR.96.6.1750
    Open DOISearch in Google Scholar
  16. 16. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005; 28(5):1231-39. DOI: 10.2337/diacare.28.5.1231
    Open DOISearch in Google Scholar
  17. 17. Ward WK, Castle JR, Jacobs PG, Cargill RS. Can glucose be monitored accurately at the site of subcutaneous insulin delivery? J Diabetes Sci Technol. 2014;8(3):568-74. DOI: 10.1177/1932296814522805
    Open DOISearch in Google Scholar
  18. 18. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W. GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol. 2011; 5(2):447–51. DOI: 10.1177/193229681100500236
    Open DOISearch in Google Scholar
  19. 19. Khadilkar KS, Bandgar T, Shivane V, Lila A, Shah N. Current concepts in blood glucose monitoring. Indian J Endocrinol Metab. 2013;17(Suppl 3):S643–9. DOI: 10.4103/2230-8210.123556
    Open DOISearch in Google Scholar
  20. 20. Higuchi T. Approach to an irregular time series on the basis of the fractal theory. Physica D. 1988;31(2):277–83. DOI: 10.1016/0167-2789(88)90081-4
    Open DOISearch in Google Scholar
  21. 21. Monnier L, Colette C, Dejager S, Owens D. The dawn phenomenon in type 2 diabetes: How to assess it in clinicalpractice? Diabetes Metab. 2015;41(2):132-7. DOI: 10.1016/j.diabet.2014.10.002
    Open DOISearch in Google Scholar
  22. 22. Directive 2001/20/CE of the European Parliament and of the council of 4April 2001 on the approximation of the laws, regulations and administrativeprovisions of the Member States relating to the implementation of goodclinical trials on medicinal products for human use. Off J Eur Communities. 2001;L121:33–44.
    Search in Google Scholar
  23. 23. Monnier L, Colette C, Sardinoux M, Baptista G, Regnier-Zerbib A, Owens D. Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to age. Diabetes Care. 2012;35(12):2597-9. DOI: 10.2337/dc12-0385
    Open DOISearch in Google Scholar
  24. 24. Boden G, Chen X, Urbain JL. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes. 1996;45(8):1044–50. DOI: 10.2337/diabetes.45.8.1044 DOI: 10.2337/diab.45.8.1044
    Open DOISearch in Google Scholar
  25. 25. Porcellati F, Lucidi P, Cioli P, Candeloro P, Marinelli Andreoli A, Marzotti S et al. Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes. Diabetes Care. 2015 Mar;38(3):503-12. DOI: 10.2337/dc14-0649
    Open DOISearch in Google Scholar
  26. 26. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7. DOI: 10.1001/jama.295.14.1681
    Open DOISearch in Google Scholar
  27. 27. Wójcicki JM. “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res. 1995;27(1):41–42. DOI: 10.1055/s-2007-979906
    Open DOISearch in Google Scholar
  28. 28. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther. 2005;7(2):253–63. DOI: 10.1089/dia.2005.7.253
    Open DOISearch in Google Scholar
  29. 29. Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia. 1972;8(5):342–348. DOI: 10.1007/BF01218495
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2016-0004 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English
Page range: 55 - 64
Submitted on: Oct 8, 2015
Accepted on: Jan 6, 2016
Published on: Mar 19, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
dawn phenomenon,
glycemic variability,
continuous glucose monitoring
Related subjects:
Life sciences,
Molecular biology

© 2016 Gabriela Roman, Cornelia Bala, Cristian Ioan Craciun, Adriana Rusu, Anca Elena Craciun, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 24 (2016): Issue 1 (March 2016)
Previous article
Next article